Cargando…
Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer
Aminopeptidase N, also known as CD13, has been reported to be overexpressed in several cancers and may contribute to tumor metastasis and angiogenesis. The aim of this study was to evaluate whether serum APN/CD13 could be a potential biomarker for the diagnosis and prognosis of pancreatic cancer (PC...
Autores principales: | Pang, Li, Zhang, Nan, Xia, Yan, Wang, Dawei, Wang, Guoqing, Meng, Xiangwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363626/ https://www.ncbi.nlm.nih.gov/pubmed/27788483 http://dx.doi.org/10.18632/oncotarget.12835 |
Ejemplares similares
-
The Role of the Ectopeptidase APN/CD13 in Cancer
por: Lendeckel, Uwe, et al.
Publicado: (2023) -
Extracellular cysteines define ectopeptidase (APN, CD13) expression and function
por: Firla, Beate, et al.
Publicado: (2002) -
Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors
por: Yang, Kanghui, et al.
Publicado: (2009) -
Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells
por: Terauchi, Mikio, et al.
Publicado: (2007) -
Aminopeptidase N (APN/CD13) as a target molecule for scirrhous gastric cancer
por: Nohara, Shigeo, et al.
Publicado: (2016)